Multiple Sclerosis Relapsing-remitting
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis Relapsing-remitting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)
An observational study evaluating Rebismart 2.0 plus MSdialog in relapsing-remitting multiple sclerosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study
This completed clinical trial update reports on a study assessing lesion activity in relapsing-remitting multiple sclerosis patients treated…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Pharmacokinetics of Vitamin D in Multiple Sclerosis and in Health [NA]
Clinical trial update reporting pharmacokinetics of vitamin D in multiple sclerosis and healthy individuals; study completed with posted res…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One [Phase 3]
Phase 3 head-to-head trial comparing alemtuzumab with Rebif in relapsing-remitting multiple sclerosis has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or Sleepiness [Phase 4]
Phase 4 trial assessing natalizumab’s effects on sleep parameters in relapsing-remitting multiple sclerosis patients experiencing fatigue or…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing-Remitting Multiple Sclerosis Subjects [Phase 3]
Phase 3 trial evaluating the tolerability of Rebif injections in relapsing-remitting multiple sclerosis with and without the Rebiject Mini a…
-
CLINICAL_TRIALS trial_result · 2013-08-05Clinical Trial Update: A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS) [Phase 3]
A Phase 3 study comparing Rebif and Avonex for relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Efficacy and Safety of Methylprednisolone Per os Versus IV for the Treatment of Multiple Sclerosis (MS) Relapses [Phase 3]
Phase 3 clinical trial evaluating oral methylprednisolone versus intravenous methylprednisolone for treatment of relapses in relapsing-remit…
-
CLINICAL_TRIALS trial_result · 2012-01-30Clinical Trial Update: COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS
A Biogen-sponsored trial evaluating compliance with Avonex PS in patients with relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
Completed real-world study assessing the health economic outcomes of Betaseron in relapsing forms of multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis [Phase 2]
A Phase II trial compared low- and high-dose alemtuzumab with high-dose Rebif in patients with early active relapsing-remitting multiple scl…
-
CLINICAL_TRIALS trial_result · 2009-06-18Clinical Trial Update: Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluates the safety and efficacy of combining natalizumab with Avonex for relapsing-remitting multiple sclerosis; the study…